A detailed history of Abbrea Capital, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Abbrea Capital, LLC holds 4,519 shares of MDT stock, worth $389,854. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,519
Previous 5,077 10.99%
Holding current value
$389,854
Previous $446,000 19.51%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$78.71 - $87.02 $43,920 - $48,557
-558 Reduced 10.99%
4,519 $359,000
Q1 2024

May 07, 2024

BUY
$82.84 - $88.09 $10,355 - $11,011
125 Added 2.52%
5,077 $446,000
Q4 2023

Feb 02, 2024

SELL
$69.43 - $83.43 $85,398 - $102,618
-1,230 Reduced 19.9%
4,952 $411,000
Q3 2023

Oct 31, 2023

SELL
$78.22 - $90.4 $3,519 - $4,068
-45 Reduced 0.72%
6,182 $489,000
Q2 2023

Aug 01, 2023

BUY
$79.47 - $91.38 $43,787 - $50,350
551 Added 9.71%
6,227 $553,000
Q1 2023

May 11, 2023

BUY
$76.72 - $87.58 $49,330 - $56,313
643 Added 12.78%
5,676 $461,000
Q4 2022

Feb 08, 2023

SELL
$76.18 - $87.74 $96,748 - $111,429
-1,270 Reduced 20.15%
5,033 $391,000
Q3 2022

Nov 03, 2022

SELL
$80.75 - $95.31 $26,566 - $31,356
-329 Reduced 4.96%
6,303 $513,000
Q2 2022

Aug 02, 2022

BUY
$87.4 - $113.09 $9,788 - $12,666
112 Added 1.72%
6,632 $600,000
Q1 2022

May 11, 2022

BUY
$100.58 - $112.38 $39,729 - $44,390
395 Added 6.45%
6,520 $728,000
Q4 2021

Feb 04, 2022

SELL
$99.53 - $127.75 $33,840 - $43,435
-340 Reduced 5.26%
6,125 $637,000
Q3 2021

Nov 04, 2021

SELL
$122.75 - $135.17 $19,640 - $21,627
-160 Reduced 2.42%
6,465 $814,000
Q2 2021

Aug 04, 2021

SELL
$118.19 - $131.5 $9,927 - $11,046
-84 Reduced 1.25%
6,625 $827,000
Q1 2021

May 13, 2021

BUY
$111.18 - $119.74 $10,450 - $11,255
94 Added 1.42%
6,709 $796,000
Q4 2020

Jan 21, 2021

BUY
$100.57 - $117.14 $40,228 - $46,856
400 Added 6.44%
6,615 $779,000
Q3 2020

Oct 20, 2020

SELL
$90.13 - $108.78 $28,571 - $34,483
-317 Reduced 4.85%
6,215 $649,000
Q2 2020

Aug 11, 2020

SELL
$84.11 - $103.33 $22,962 - $28,209
-273 Reduced 4.01%
6,532 $603,000
Q1 2020

Apr 29, 2020

SELL
$72.92 - $121.3 $20,782 - $34,570
-285 Reduced 4.02%
6,805 $617,000
Q4 2019

Feb 11, 2020

BUY
$104.49 - $114.54 $30,302 - $33,216
290 Added 4.26%
7,090 $808,000
Q3 2019

Nov 07, 2019

BUY
$98.02 - $111.18 $67,633 - $76,714
690 Added 11.29%
6,800 $742,000
Q2 2019

Jul 31, 2019

BUY
$84.15 - $99.38 $149,029 - $176,001
1,771 Added 40.82%
6,110 $595,000
Q1 2019

May 08, 2019

SELL
$82.45 - $93.79 $3,710 - $4,220
-45 Reduced 1.03%
4,339 $397,000
Q4 2018

Feb 05, 2019

BUY
$85.8 - $99.49 $10,982 - $12,734
128 Added 3.01%
4,384 $401,000
Q3 2018

Nov 09, 2018

BUY
$85.91 - $99.17 $18,900 - $21,817
220 Added 5.45%
4,256 $421,000
Q2 2018

Aug 08, 2018

BUY
$77.48 - $87.83 $9,297 - $10,539
120 Added 3.06%
4,036 $346,000
Q1 2018

May 10, 2018

BUY
$76.55 - $87.26 $18,218 - $20,767
238 Added 6.47%
3,916 $316,000
Q4 2017

Feb 01, 2018

SELL
$76.93 - $83.5 $3,154 - $3,423
-41 Reduced 1.1%
3,678 $299,000
Q3 2017

Nov 07, 2017

BUY
$77.71 - $84.6 $289,003 - $314,627
3,719
3,719 $291,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.